Discover

DLB
Dolby Laboratories, Inc.
57.65
1400 x 56.25
600 x 57.69
bid
ask
+
0.18
0.31%
1000 @ 07:30 PM
57.65 +0.00 (0.00%)
Ytd-10.23%
1y-20.04%
57.07
day range
57.84
48.51
52 week range
72.67
Open57.54Prev Close57.47Low57.07High57.84Mkt Cap5.40B
Vol2.11MAvg Vol957.62KEPS2.35P/E24.53Forward P/E12.60
Beta0.80Short Ratio5.58Inst. Own106.40%Dividend1.44Div Yield2.51
Ex Div Date08-11Earning11-1750-d Avg58.21200-d Avg60.201yr Est79.00

DLB News

Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan
prnewswire.com
Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan

SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB) ("Dolby"), a lead

Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026
prnewswire.com
Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026

New Sports Intelligence helps providers better understand and deepen fan engagement, as Dolby Vision

Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy?
zacks.com
Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds
zacks.com
3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds

Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are l

Dolby Laboratories (DLB) is a Top-Ranked Momentum Stock: Should You Buy?
zacks.com
Dolby Laboratories (DLB) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Critical Review: Artificial Life (OTCMKTS:ALIF) & Dolby Laboratories (NYSE:DLB)
defenseworld.net
Critical Review: Artificial Life (OTCMKTS:ALIF) & Dolby Laboratories (NYSE:DLB)

Artificial Life (OTCMKTS:ALIF - Get Free Report) and Dolby Laboratories (NYSE: DLB - Get Free Report

Dolby Laboratories Announces Leadership Transition
prnewswire.com
Dolby Laboratories Announces Leadership Transition

Kevin Yeaman to Retire from Dolby  Marc Whitten Named President, Chief Executive Officer and Directo

Cinemo, Dolby, and SmashLabs Bring In-Car Immersive Gaming Experiences to the Next Level
gurufocus.com
Cinemo, Dolby, and SmashLabs Bring In-Car Immersive Gaming Experiences to the Next Level

Cinemo, a global leader and one-stop-shop provider for fully integrated, innovative multi-device in-

Dividend Champion, Contender, And Challenger Highlights: Week August 16
seekingalpha.com
Dividend Champion, Contender, And Challenger Highlights: Week August 16

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies

Assenagon Asset Management S.A. Has $5.48 Million Position in Dolby Laboratories $DLB
defenseworld.net
Assenagon Asset Management S.A. Has $5.48 Million Position in Dolby Laboratories $DLB

Assenagon Asset Management S.A. increased its stake in shares of Dolby Laboratories (NYSE: DLB) by 8

Here's Why Dolby Laboratories (DLB) is a Strong Growth Stock
zacks.com
Here's Why Dolby Laboratories (DLB) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)
globenewswire.com
CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Lice

Innovation Passport award designed to support accelerated time to market and help expedite patient a

Can Dolby's Fiscal Q4 Growth Outlook Overcome Licensing Volatility?
zacks.com
Can Dolby's Fiscal Q4 Growth Outlook Overcome Licensing Volatility?

Dolby targets a sharp fiscal Q4 rebound as content deals, auto Atmos growth and licensing gains face

Is Dolby Stock Worth Buying as Growth Meets Near-Term Execution Risks?
zacks.com
Is Dolby Stock Worth Buying as Growth Meets Near-Term Execution Risks?

Dolby's discounted valuation and $756 million cash balance support its long-term case as premium for

Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 Billion
benzinga.com
Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 Billion

Amazon surges 15% on an AWS blowout while Apple sheds nearly $475 billion in value. Yields sit at cy

Why Dolby Labs Stock Popped Today
fool.com
Why Dolby Labs Stock Popped Today

Dolby beat on earnings but missed on sales last night. Both earnings and sales declined year over ye

AXT Posts Upbeat Q2 Earnings, Joins Newell Brands, SPX Technologies, Amazon And Other Big Stocks Moving Higher On Friday
benzinga.com
AXT Posts Upbeat Q2 Earnings, Joins Newell Brands, SPX Technologies, Amazon And Other Big Stocks Mov

U.S. stocks mixed, Nasdaq up 50 pts. AXT Inc (NASDAQ: AXTI) rose 25.3% on strong Q2 results. Other g

Dolby's Q3 Earnings Beat Estimates on Lower Operating Expenses
zacks.com
Dolby's Q3 Earnings Beat Estimates on Lower Operating Expenses

DLB beat Q3 earnings estimates despite lower revenue, then forecast strong Q4 growth backed by video

Dolby Laboratories Q3 Earnings Call Highlights
marketbeat.com
Dolby Laboratories Q3 Earnings Call Highlights

Dolby Laboratories NYSE: DLB reported third-quarter fiscal 2026 revenue of $305 million, within its

Dolby Laboratories (DLB) Q3 Earnings Beat Estimates
zacks.com
Dolby Laboratories (DLB) Q3 Earnings Beat Estimates

Dolby Laboratories (DLB) came out with quarterly earnings of $0.69 per share, beating the Zacks Cons

Dolby Laboratories (DLB) Reports Q3 Earnings: What Key Metrics Have to Say
zacks.com
Dolby Laboratories (DLB) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Dolby Laboratories (DLB) give a sense of how its business performed

Dolby Laboratories, Inc. (DLB) Q3 2026 Earnings Call Transcript
seekingalpha.com
Dolby Laboratories, Inc. (DLB) Q3 2026 Earnings Call Transcript

Dolby Laboratories, Inc. (DLB) Q3 2026 Earnings Call Transcript

benzinga.com
Dolby Laboratories Lowers FY2026 GAAP EPS Guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.83 Est

Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.

benzinga.com
Dolby Laboratories Lowers FY2026 Adj EPS Guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 Est; Narr

Dolby Laboratories (NYSE:DLB) lowers FY2026 Adj EPS guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.3

benzinga.com
Dolby Laboratories Sees Q4 Adj EPS $1.13-$1.28 vs $1.20 Est; Sees Sales $362.000M-$392.000M vs $351.

Dolby Laboratories (NYSE:DLB) is looking for Q4 Adj EPS of $1.13-$1.28 vs $1.20 analyst estimate. se

benzinga.com
Dolby Laboratories Q3 Adj. EPS $0.69 Beats $0.67 Estimate, Sales $304.995M Miss $311.960M Estimate

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.69 per share which beat the analyst

Top 3 Tech Stocks That May Rocket Higher In July
benzinga.com
Top 3 Tech Stocks That May Rocket Higher In July

Find bargains in oversold IT stocks with RSI values below 30: Fabrinet (NYSE: FN), Dolby Laboratorie

Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU
benzinga.com
Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU

U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on

Dolby Laboratories Q2 2026 Earnings Call: Complete Transcript
benzinga.com
Dolby Laboratories Q2 2026 Earnings Call: Complete Transcript

12 Information Technology Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Information Technology Stocks Moving In Thursday's After-Market Session

benzinga.com
Dolby Laboratories Sees Q3 Adj EPS $0.56-$0.71 vs $0.98 Est; Sees Sales $295.000M-$325.000M vs $343.

Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.56-$0.71 vs $0.98 analyst estimate. se

Earnings Scheduled For April 30, 2026
benzinga.com
Earnings Scheduled For April 30, 2026

Earnings Scheduled For January 29, 2026
benzinga.com
Earnings Scheduled For January 29, 2026

12 Information Technology Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Information Technology Stocks Moving In Tuesday's After-Market Session

Earnings Scheduled For November 18, 2025
benzinga.com
Earnings Scheduled For November 18, 2025

Applied Materials To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
benzinga.com
Applied Materials To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday

benzinga.com
Earnings Scheduled For July 31, 2025

benzinga.com
Earnings Scheduled For May 1, 2025

benzinga.com
Earnings Scheduled For January 29, 2025

benzinga.com
Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday

benzinga.com
Earnings Scheduled For November 19, 2024

benzinga.com
Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company r

benzinga.com
Earnings Scheduled For February 1, 2024

Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its f

benzinga.com
Earnings Scheduled For November 16, 2023

Companies Reporting Before The Bell • Children's Place (NASDAQ:PLCE) is projected to report qua

benzinga.com
Earnings Scheduled For August 3, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

benzinga.com
Earnings Scheduled For May 4, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 838 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's session, 402 companies made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 456 stocks hit new 52-week lows.

benzinga.com
Earnings Scheduled For August 9, 2022

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor